These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
96 related articles for article (PubMed ID: 22240860)
1. Paroxetine-associated hypereosinophilia may clinically resemble a panic attack. Yasui-Furukori N; Sato Y; Kato H; Kaneko S Clin Neuropharmacol; 2012; 35(1):47-8. PubMed ID: 22240860 [TBL] [Abstract][Full Text] [Related]
2. A comparison of citalopram and paroxetine in the treatment of panic disorder: a randomized, single-blind study. Perna G; Bertani A; Caldirola D; Smeraldi E; Bellodi L Pharmacopsychiatry; 2001 May; 34(3):85-90. PubMed ID: 11434404 [TBL] [Abstract][Full Text] [Related]
3. [Adverse effects after switching to a different generic form of paroxetine: paroxetine mesylate instead of paroxetine HCl hemihydrate]. Vergouwen AC; Bakker A Ned Tijdschr Geneeskd; 2002 Apr; 146(17):811-2. PubMed ID: 12014241 [TBL] [Abstract][Full Text] [Related]
4. A double-blind study of the efficacy of venlafaxine extended-release, paroxetine, and placebo in the treatment of panic disorder. Pollack MH; Lepola U; Koponen H; Simon NM; Worthington JJ; Emilien G; Tzanis E; Salinas E; Whitaker T; Gao B Depress Anxiety; 2007; 24(1):1-14. PubMed ID: 16894619 [TBL] [Abstract][Full Text] [Related]
5. Paroxetine: a review of clinical experience. Dunner D; Kumar R Pharmacopsychiatry; 1998 May; 31(3):89-101. PubMed ID: 9657236 [TBL] [Abstract][Full Text] [Related]
6. Augmentation of paroxetine with clocapramine in panic disorder. Saito M; Miyaoka H Psychiatry Clin Neurosci; 2007 Aug; 61(4):449. PubMed ID: 17610675 [No Abstract] [Full Text] [Related]
7. Induction of mania in depression by paroxetine. Morishita S; Arita S Hum Psychopharmacol; 2003 Oct; 18(7):565-8. PubMed ID: 14533140 [TBL] [Abstract][Full Text] [Related]
8. Lower gastrointestinal bleeding and paroxetine use: two case reports. Blasco-Fontecilla H; de Leon J Psychosomatics; 2012; 53(2):184-7. PubMed ID: 22424167 [No Abstract] [Full Text] [Related]
9. Possible neuroleptic malignant syndrome related to concomitant treatment with paroxetine and alprazolam. Tanii H; Ichihashi K; Inoue K; Fujita K; Okazaki Y Prog Neuropsychopharmacol Biol Psychiatry; 2006 Aug; 30(6):1176-8. PubMed ID: 16720068 [TBL] [Abstract][Full Text] [Related]
10. An open-label trial of nefazodone in high comorbidity panic disorder. DeMartinis NA; Schweizer E; Rickels K J Clin Psychiatry; 1996 Jun; 57(6):245-8. PubMed ID: 8666561 [TBL] [Abstract][Full Text] [Related]
11. Hair loss associated with paroxetine treatment: a case report. Zalsman G; Sever J; Munitz H Clin Neuropharmacol; 1999; 22(4):246-7. PubMed ID: 10442258 [TBL] [Abstract][Full Text] [Related]
12. Hallucination induced by paroxetine discontinuation in patients with major depressive disorders. Yasui-Furukori N; Kaneko S Psychiatry Clin Neurosci; 2011 Jun; 65(4):384-5. PubMed ID: 21489048 [TBL] [Abstract][Full Text] [Related]
13. A double-blind, placebo-controlled study of quetiapine and paroxetine as monotherapy in adults with bipolar depression (EMBOLDEN II). McElroy SL; Weisler RH; Chang W; Olausson B; Paulsson B; Brecher M; Agambaram V; Merideth C; Nordenhem A; Young AH; J Clin Psychiatry; 2010 Feb; 71(2):163-74. PubMed ID: 20122366 [TBL] [Abstract][Full Text] [Related]
14. A case of serial nightmares and oneiroid state under paroxetine for senile depression. Kobayashi T; Yamauchi M Psychogeriatrics; 2012 Mar; 12(1):54-7. PubMed ID: 22416829 [TBL] [Abstract][Full Text] [Related]
15. Serotonin syndrome after lithium add-on medication to paroxetine. Sobanski T; Bagli M; Laux G; Rao ML Pharmacopsychiatry; 1997 May; 30(3):106-7. PubMed ID: 9211572 [TBL] [Abstract][Full Text] [Related]
16. [Narcoleptic syndrome as a possible side effect of paroxetine]. Alonso H; Ortí-Pareja M; Jiménez-Jiménez FJ Rev Neurol; 2004 Dec 1-15; 39(11):1092. PubMed ID: 15597274 [No Abstract] [Full Text] [Related]
17. Duloxetine in the acute and long-term treatment of major depressive disorder: a placebo- and paroxetine-controlled trial. Detke MJ; Wiltse CG; Mallinckrodt CH; McNamara RK; Demitrack MA; Bitter I Eur Neuropsychopharmacol; 2004 Dec; 14(6):457-70. PubMed ID: 15589385 [TBL] [Abstract][Full Text] [Related]
18. [Alopecia due to Seroxat therapy]. Umansky L; Dorevitch A; Sella A Harefuah; 2000 Apr; 138(7):547-9, 614. PubMed ID: 10883182 [TBL] [Abstract][Full Text] [Related]
19. Withdrawal hypomania associated with paroxetine. Landry P; Roy L J Clin Psychopharmacol; 1997 Feb; 17(1):60-1. PubMed ID: 9004064 [No Abstract] [Full Text] [Related]
20. Comparison of Hypericum extract WS 5570 and paroxetine in ongoing treatment after recovery from an episode of moderate to severe depression: results from a randomized multicenter study. Anghelescu IG; Kohnen R; Szegedi A; Klement S; Kieser M Pharmacopsychiatry; 2006 Nov; 39(6):213-9. PubMed ID: 17124643 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]